IP Library › Assignment 033544/0324
Patent Assignment
Reel/Frame 033544/0324

Release of Security Interest

Recorded: 2014-08-14 Pages: 5
Assignor
Assignee
SIGA TECHNOLOGIES INC.
660 MADISON AVENUE, SUITE 1700, NEW YORK, NEW YORK, 10065
Covered Properties (17)
Sulfonyl Semicarbazides, Carbonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Patent: 7,994,221 →
Application: 11/653,972 →
Publication: US 2010/0256096
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 7,872,037 →
Application: 11/712,918 →
Publication: US 2007/0254934
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses
Patent: 8,642,596 →
Application: 11/791,926 →
Publication: US 2009/0203675
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 7,977,365 →
Application: 12/111,778 →
Publication: US 2008/0300265
Anti-Arenaviral Compounds
Patent: 8,106,058 →
Application: 12/162,395 →
Publication: US 2009/0180980
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,148,428 →
Application: 12/281,081 →
Publication: US 2009/0036513
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,461,177 →
Application: 12/673,983 →
Publication: US 2011/0064693
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,623,347 →
Application: 12/735,392 →
Publication: US 2011/0027227
Anti-Viral Drugs for Treatment of Arenavirus Infection
Patent: 8,629,170 →
Application: 12/912,325 →
Publication: US 2011/0172281
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Patent: 8,410,149 →
Application: 12/914,400 →
Publication: US 2012/0022027
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Patent: 8,658,697 →
Application: 12/925,702 →
Publication: US 2011/0118505
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses
Patent: 8,664,274 →
Application: 13/176,866 →
Publication: US 2013/0261087
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,871,746 →
Application: 13/293,849 →
Publication: US 2012/0071447
Anti-Arenaviral Compounds
Patent: 8,518,951 →
Application: 13/338,726 →
Publication: US 2012/0107276
Anti-Arenaviral Compounds
Patent: 8,791,110 →
Application: 13/339,478 →
Publication: US 2012/0308519
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 9,199,920 →
Application: 13/402,125 →
Publication: US 2012/0149751
Antiviral Drugs for Treatment of Arenavirus Infection
Patent: 8,492,434 →
Application: 13/402,167 →
Publication: US 2013/0165493
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License Jul 16, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028557/0498 →
Confirmatory License Jul 16, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028557/0522 →
Confirmatory License Jul 17, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028571/0641 →
Assignment of Assignor's Interest Aug 21, 2012
From: AMBERG, SEAN M.; DAI, DONGCHENG; BOLKEN, TOVE' C.; HRUBY, DENNIS E.
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 028821/0404 →
Confirmatory License Oct 18, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029151/0189 →
Security Agreement Dec 31, 2012
From: SIGA TECHNOLOGIES, INC.
To: GE CAPITAL EQUITY INVESTMENTS, INC. C/O GE HEALTHCARE FINANCIAL SERVICES, INC.
Reel/Frame 029557/0771 →
Assignment of Assignor's Interest Aug 22, 2014
From: SIGA TECHNOLOGIES INC.
To: KINETA FOUR LLC
Reel/Frame 033588/0427 →
Release of Security Interest Apr 2, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 035319/0001 →
Confirmatory License May 29, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052796/0611 →
Confirmatory License May 29, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052796/0609 →
Confirmatory License Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0656 →
Confirmatory License Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0766 →
Confirmatory License Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0736 →